- recruitingPHASE3
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
This study looks at the long-term safety of a medicine called guselkumab for children and young people with Crohn's disease, ulcerative colitis, or a type of arthritis called juvenile psoriatic arthritis. It's for those who have already seen benefits from the medicine in an earlier study.
United States · Argentina · Australia - active not recruitingPHASE4
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
This study is looking at a new treatment called guselkumab for people with psoriatic arthritis that affects the spine and pelvis. It aims to see how well it reduces pain and inflammation in these areas. Participants will receive either the study drug or a dummy treatment.
United States · Argentina · Australia - active not recruiting
A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice
This study looks at how well new and existing treatments for Psoriatic Arthritis, called guselkumab and IL-17 inhibitors, work in people's everyday lives. It aims to understand how long people stay on these medicines and their real-world impact.
Argentina · Australia · Austria - recruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
This study is looking at a new medicine called icotrokinra for people with psoriatic arthritis. We want to see if it helps reduce joint pain and swelling, and if it's safe. Some people will get the new medicine, others a dummy medicine.
United States · Argentina · Australia - active not recruitingPHASE3
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis
This study is testing a new medicine called icotrokinra for people with active psoriatic arthritis who haven't tried biological treatments before. We want to see if it helps reduce symptoms and if it's safe to use, compared to a dummy treatment or an existing one.
United States · Argentina · Australia - active not recruitingPHASE3
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug
This study is looking at a new medicine called sonelokimab for people with psoriatic arthritis who haven't tried powerful biologic drugs before. It wants to see if sonelokimab is safe and helps improve their arthritis and skin.
United States · Bulgaria · Canada - recruitingPHASE3
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
This study is testing a new medicine called sonelokimab for adults with psoriatic arthritis that hasn't responded well to previous treatments. We want to see if it's safe and helps improve their symptoms compared to a dummy treatment or an existing medicine.
United States · Bulgaria · Canada - recruitingNA
Influence of Sodium Intake in spondyLoarthriTes
This study looks into whether the amount of salt people with spondyloarthritis eat affects their condition. It aims to see if there's a link between salt intake and how active the disease is in people with certain types of arthritis.
France - recruiting
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
This study looks at how well a medicine called guselkumab works for people with psoriatic arthritis over one year. It's for adults already using this treatment as part of their regular care to see if they continue with it.
France - active not recruitingPHASE3
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
This study is looking at a new medicine called guselkumab for people with psoriatic arthritis. It aims to see how well it reduces pain, swelling, and other symptoms compared to a dummy treatment, and if it helps improve their condition.
United States · Australia · Bosnia and Herzegovina - active not recruitingPHASE3
A Long-term Extension Study of Ustekinumab in Pediatric Participants
This study looks at the long-term safety of a treatment called ustekinumab for children and young people with conditions like Crohn's disease or certain types of arthritis. It's for those already taking part in an earlier study of this medicine.
United States · Argentina · Belgium